- Home
- ITT vs ICLR Comparison
ITT vs ICLR Comparison
Compare ITT & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ITT | ICLR |
|---|---|---|
| Founded | 1920 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Fluid Controls | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.4B | 14.3B |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | ITT | ICLR |
|---|---|---|
| Price | $181.17 | $185.83 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 14 |
| Target Price | $201.11 | ★ $201.23 |
| AVG Volume (30 Days) | 592.3K | ★ 1.0M |
| Earning Date | 10-29-2025 | 10-22-2025 |
| Dividend Yield | ★ 0.78% | N/A |
| EPS Growth | ★ 2.16 | N/A |
| EPS | 5.99 | ★ 7.47 |
| Revenue | $3,813,500,000.00 | ★ $8,102,602,000.00 |
| Revenue This Year | $7.91 | N/A |
| Revenue Next Year | $5.90 | $0.76 |
| P/E Ratio | $30.21 | ★ $24.87 |
| Revenue Growth | ★ 8.01 | N/A |
| 52 Week Low | $105.64 | $125.10 |
| 52 Week High | $197.07 | $228.29 |
Technical Indicators
Market Signals| Indicator | ITT | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 47.61 | 62.18 |
| Support Level | $177.48 | $174.13 |
| Resistance Level | $183.44 | $191.15 |
| Average True Range (ATR) | 5.03 | 8.46 |
| MACD | -0.46 | 2.87 |
| Stochastic Oscillator | 53.79 | 85.77 |
Price Performance
Historical ComparisonAbout ITT ITT Inc.
ITT began its journey as International Telephone & Telegraph in 1920. Through decades of acquisitions in the mid-1900s, ITT went from manufacturing telephone switching equipment to operating hotels, car rentals, insurance agencies, and bread bakeries. In 1995, the firm split into three separate entities, one of which is the ITT in current operation. After a few more spinoffs in 2011, today ITT Inc. sells automotive, industrial, and aerospace products such as brake pads, seals, pumps, valves, connectors, and regulators. It has operations around the globe with notable exposures to North America, Europe, and Asia.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.